Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral: Vanier Canada Graduate Scholarships

University of Calgary

$150,000.00

Evaluating the effectiveness of 6-month Isoniazid Preventive Therapy amongst people living with HIV in KwaZulu-Natal, South Africa

FY 2012-13

Summary
Despite the fact that tuberculosis (TB) is a curable disease, it remains the number one cause of death amongst people with AIDS globally. South Africa has the highest number of people living with HIV (5.6 million) and the highest incidence of TB and HIV-TB worldwide (981 and 591 per 100 000, respectively). Latent TB infection (LTBI) is a dormant stage preceding TB disease. Although treatment for LTBI in the form of Isoniazid Preventive Therapy (IPT) has been commonly used in the developed world, it has not been used in countries with high HIV-TB incidence until now. In 2011, IPT became available community-wide to people living with HIV (PLWH) in the Edendale Hospital catchment of KwaZulu-Natal, South Africa (an area of high TB-HIV and MDR-TB prevalence). The present project will follow up all charts of PLWH who completed 6-months of IPT in the catchment area between Dec 1, 2011 and June 30, 2012 to determine changes in TB incidence, TB mortality, and all cause mortality among PLWH compared with previous years. The PhD candidate will also interview a subset of PLWH declining, discontinuing, or completing the IPT regimen to learn more about the experience of patients. The project will build upon a catalyst project which helped to develop community partnerships and identify community perceptions of population-wide IPT. Pre-established advisory teams in a random sample of six Edendale communities will help determine sub-objectives, interview tools, and culturally competent findings and dissemination methods. This study will be the first opportunity globally to evaluate the effectiveness of IPT in a high TB-HIV co-infected environment, as South Africa is the first country to formally adopt the practice of community-wide IPT for PLWH. Findings will directly affect local and international policy guidelines on the use of IPT among PLWH.
Program
Doctoral: Vanier Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
273553
Name
Boffa Jody M
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Evaluating the effectiveness of 6-month Isoniazid Preventive Therapy amongst people living with HIV in KwaZulu-Natal, South Africa
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Hiv-Tb Co-Infection; Isoniazid Preventive Therapy; Mixed-Methodology; Population-Based Effectiveness Trial; Tuberculosis
Abstract
Despite the fact that tuberculosis (TB) is a curable disease, it remains the number one cause of death amongst people with AIDS globally. South Africa has the highest number of people living with HIV (5.6 million) and the highest incidence of TB and HIV-TB worldwide (981 and 591 per 100 000, respectively). Latent TB infection (LTBI) is a dormant stage preceding TB disease. Although treatment for LTBI in the form of Isoniazid Preventive Therapy (IPT) has been commonly used in the developed world, it has not been used in countries with high HIV-TB incidence until now. In 2011, IPT became available community-wide to people living with HIV (PLWH) in the Edendale Hospital catchment of KwaZulu-Natal, South Africa (an area of high TB-HIV and MDR-TB prevalence). The present project will follow up all charts of PLWH who completed 6-months of IPT in the catchment area between Dec 1, 2011 and June 30, 2012 to determine changes in TB incidence, TB mortality, and all cause mortality among PLWH compared with previous years. The PhD candidate will also interview a subset of PLWH declining, discontinuing, or completing the IPT regimen to learn more about the experience of patients. The project will build upon a catalyst project which helped to develop community partnerships and identify community perceptions of population-wide IPT. Pre-established advisory teams in a random sample of six Edendale communities will help determine sub-objectives, interview tools, and culturally competent findings and dissemination methods. This study will be the first opportunity globally to evaluate the effectiveness of IPT in a high TB-HIV co-infected environment, as South Africa is the first country to formally adopt the practice of community-wide IPT for PLWH. Findings will directly affect local and international policy guidelines on the use of IPT among PLWH.
Competitiondate
201211
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Boffa, Jody M
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~
University of Calgary - $150,000 Grant (2012-13) | Canada Spends